Granahan Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Granahan Investment Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,528	Closed	-$1.02M	–	183
2022 Q1	$1.02M	Sell	14,528 -96,305	-87%	-$6.75M	0.03%	173
2021 Q4	$10.7M	Sell	110,833 -76,771	-41%	-$7.4M	0.22%	108
2021 Q3	$16.3M	Sell	187,604 -72,988	-28%	-$6.34M	0.31%	80
2021 Q2	$21.3M	Sell	260,592 -140,857	-35%	-$11.5M	0.4%	62
2021 Q1	$38.2M	Buy	401,449 +91,527	+30%	+$8.7M	0.81%	36
2020 Q4	$19.2M	Buy	309,922 +169,142	+120%	+$10.5M	0.43%	59
2020 Q3	$8.37M	Buy	140,780 +65,635	+87%	+$3.9M	0.28%	84
2020 Q2	$5.24M	Sell	75,145 -5,829	-7%	-$407K	0.19%	106
2020 Q1	$3.67M	Buy	80,974 +61,865	+324%	+$2.81M	0.2%	99
2019 Q4	$1.24M	Sell	19,109 -13,842	-42%	-$900K	0.06%	154
2019 Q3	$2.05M	Buy	32,951 +4,833	+17%	+$300K	0.11%	139
2019 Q2	$2M	Sell	28,118 -26,503	-49%	-$1.89M	0.1%	142
2019 Q1	$4.28M	Sell	54,621 -60,995	-53%	-$4.78M	0.23%	106
2018 Q4	$9.79M	Buy	115,616 +74,116	+179%	+$6.27M	0.69%	51
2018 Q3	$7.11M	Buy	41,500 +12,814	+45%	+$2.19M	0.39%	81
2018 Q2	$3.71M	Sell	28,686 -25,067	-47%	-$3.24M	0.22%	118
2018 Q1	$5.54M	Sell	53,753 -8,586	-14%	-$885K	0.4%	85
2017 Q4	$5.33M	Buy	62,339 +5,798	+10%	+$495K	0.42%	85
2017 Q3	$4.8M	Buy	56,541 +4,171	+8%	+$354K	0.4%	90
2017 Q2	$3.97M	Buy	52,370 +4,359	+9%	+$330K	0.37%	94
2017 Q1	$3.17M	Sell	48,011 -472,964	-91%	-$31.2M	0.32%	101
2016 Q4	$33M	Buy	520,975 +31,380	+6%	+$1.99M	1.13%	21
2016 Q3	$31.2M	Sell	489,595 -31,098	-6%	-$1.98M	1.02%	20
2016 Q2	$38.7M	Sell	520,693 -92,653	-15%	-$6.89M	1.41%	7
2016 Q1	$41M	Buy	613,346 +38,472	+7%	+$2.57M	1.49%	7
2015 Q4	$38.9M	Sell	574,874 -51,899	-8%	-$3.51M	1.34%	9
2015 Q3	$33.5M	Buy	626,773 +66,364	+12%	+$3.55M	1.04%	19
2015 Q2	$35.3M	Buy	560,409 +340,317	+155%	+$21.4M	1%	25
2015 Q1	$10.6M	Buy	+220,092	New	+$10.6M	0.3%	124